loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of All Manufacturers & Suppliers for 210259 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

    Client Virtual Booth
    Menu

    AstraZeneca

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 ACALABRUTINIB (1)

    filter

    01 ASTRAZENECA (1)

    filter

    01 CAPSULE;ORAL (1)

    filter

    01 100MG (1)

    filter

    01 USA (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Acalabrutinib

    PDF Supplier PDF
    URL Supplier Web Content
    CAPSULE;ORAL
    100MG
    CALQUENCE
    USA
    210259
    2017-10-31
    RX
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for CTD TGA MCC DOSSIER APPLICATION 210259

    Looking for CTD TGA MCC DOSSIER APPLICATION 210259 1

    19

    AstraZeneca, based in United Kingdom, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their notable products is ACALABRUTINIB, with a corresponding application number 210259 and regulatory information .

    proudly manufactured in the

    approval since 2017-10-31

    AstraZeneca's CALQUENCE CAPSULE;ORAL, medication with 100MG of ACALABRUTINIB.

    Post Enquiry
    POST ENQUIRY